Association between kinase insert domain-containing receptor gene polymorphisms and silent brain infarction: A Korean study

Journal of the Neurological Sciences

Volumn 318, Issue 1-2, 2012, Pages 85-89

  Han, In Bo ^a   Kim, Ok Joon ^a   Ropper, Alexander E ^b   Kim, Hyun Seok ^a   Cho, Yun Kyung ^a   Teng, Yang D ^b   Kim, Nam Keun ^a  

^a CHA University   (South Korea)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Genotype; Kinase insert domain containing receptor; Polymorphism; Silent brain infarction; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; BRAIN INFARCTION; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; REPUBLIC OF KOREA; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84861635394     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.03.020     Document Type: Article

References (33)

1. Y. Notsu, T. Nabika, H.Y. Park, J. Masuda, and S. Kobayashi Evaluation of genetic risk factors for silent brain infarction Stroke 30 1999 1881 1886
2. S.H. Oh, N.K. Kim, S.H. Kim, J.K. Kim, H.S. Kim, and W.C. Kim The prevalence and risk factor analysis of silent brain infarction in patients with first-ever ischemic stroke J Neurol Sci 293 2010 97 101
3. I.B. Han, O.J. Kim, J.Y. Ahn, D. Oh, S.P. Hong, and R. Huh Association of methylenetetrahydrofolate reductase (MTHFR 677C>T and 1298A>C) polymorphisms and haplotypes with silent brain infarction and homocysteine levels in a Korean population Yonsei Med J 51 2010 253 260
4. S.E. Vermeer, P.J. Koudstaal, M. Oudkerk, A. Hofman, and M.M. Breteler Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study Stroke 33 2002 21 25
5. P. Cherian, G.J. Hankey, J.W. Eikelboom, J. Thom, R.I. Baker, and A. McQuillan Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes Stroke 34 2003 2132 2137
6. A. Hassan, B.J. Hunt, M. O'Sullivan, K. Parmar, J.M. Bamford, and D. Briley Markers of endothelial dysfunction in lacunar infarction and ischemic leukoaraiosis Brain 126 2003 424 432
7. S. Prabhakaran, C.B. Wright, M. Yoshita, R. Delapaz, T. Brown, and C. DeCarli Prevalence and determinants of subclinical brain infarction: the Northern Manhattan Study Neurology 70 2008 425 430
8. D. Petrovic The role of vascular endothelial growth factor gene as the genetic marker of atherothrombotic disorders and in the gene therapy of coronary artery disease Cardiovasc Hematol Agents Med Chem 8 1 2010 47 54
9. M.G. Petrovic, P. Korosec, M. Kosnik, J. Osredkar, M. Hawlina, and B. Peterlin Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy Mol Vis 14 2008 1382 1387
10. O.J. Kim, S.H. Hong, S.H. Oh, T.G. Kim, K.T. Min, and D. Oh Association between VEGF polymorphisms and homocysteine levels in patients with ischemic stroke and silent brain infarction Stroke 42 2011 2393 2402
11. T. Cacev, B. Loncar, S. Seiwerth, S. Spaventi, and S. Kapitanovic Vascular endothelial growth factor polymosphisms - 1154 G/A and - 460 C/T are not associated with VEGF mRNA expression and susceptibility to sporadic colon cancer DNA Cell Biol 27 10 2008 569 574
12. D. Ahmadvand, F. Rahbarizadeh, F.J. Iri-sofla, G. Namazi, S. Khaleghi, and B. Geramizadeh Inhibition of angiogenesis by recombinant VEGF receptor fragments Lab Med 41 2010 417 422
13. S. Jesmin, I. Sakuma, Y. Hattori, and A. Kitabatake Regulatory molecules for coronary expressions of VEGF and its angiogenic receptor KDR in hypoestrogenic middle-aged female rats Mol Cell Biochem 259 2004 189 196
14. B. Li, A.K. Ogasawara, R. Yang, W. Wei, G.W. He, and T.F. Zioncheck KDR (VEGF receptor 2) is the major mediator for the hypotensive effect of VEGF Hypertension 39 2002 1095 1100
15. F. Shalaby, J. Rossant, T.P. Yamaguchi, M. Gertsenstein, X.F. Wu, and M.L. Breitman Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice Nature 376 1995 62 66
16. S.H. Oh, K.T. Min, Y.J. Jeon, M.H. Kim, J.S. Moon, and H.S. Kim Association between kinase insert domain-containing receptor gene polymorphism and haplotypes and ischemic stroke J Neurol Sci 308 2011 62 66
17. H. Kariyazono, T. Ohno, V. Khajoee, K. ihara, K. Kusuhara, and N. Kinukawa Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease Pediatr Res 56 2004 953 959
18. D. Petrovic, R. Verhovec, M. Globocnik Petrovic, J. Osredkar, and B. Peterlin Association of vascular endothelial growth factor gene polymorphism with myocardial infarction in patients with type 2 diabetes Cardiology 107 2007 291 295
19. Y. Wang, Y. Zheng, W. Zhang, H. Yu, K. Lou, and Y. Zhang Polymorphisms of KDR gene are associated with coronary heart disease J Am Coll Cardiol 50 2007 760 767
20. W. Zhang, K. Sun, Y. Zhen, D. Wang, Y. Wang, and J. Chen VEGF receptor-2 variants are associated with susceptibility to stroke and recurrence Stroke 40 2009 2720 2726
21. J.H. Lee, D.H. Yang, H.S. Park, Y. Cho, J.E. Jun, and W.H. Park Incidence of hypertension in Korea: 5-year follow-up study J Korean Med Sci 26 2011 1286 1292
22. J.S. Sung, S.J. Cho, Y.H. Choe, Y.H. Choi, and K.P. Hong Prevalence of coronary atherosclerosis in asymptomatic middle-age men with high aerobic fitness Am J Cardiol 109 2012 839 843
23. H.M. Kwon, B.J. Kim, S.H. Lee, S.H. Choi, B.H. Oh, and B.W. Yoon Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people Stroke 37 2006 466 470
24. K. Gogat, L. Le gat, L. Van Den Berghe, D. Marchant, A. Kobetz, and S. Gadin VEGF and KDR gene expression during human embryonic and fetal eye development Invest Ophthalmol Vis Sci 45 2004 7 14
25. M. Shibuya Tyrosine kinase receptor Flt/VEGFR family: its characterization related to angiogenesis and cancer Genes Cancer 1 2010 1119 1123
26. H.P. Geber, A. McMurtey, J. Kowalski, M. Yan, B.A. Keyt, and V. Dixit Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation J Biol Chem 273 1998 30336 30343
27. H.P. Gerber, V. Dixit, and N. Ferrara Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells J Biol Chem 273 1998 13313 13316
28. M. Kuzuya, M.A. Ramos, S. Kanda, T. Koike, T. Asai, and K. Maeda VEGF protects against oxidized LDL toxicity to endothelial cells by an intracellular glutathione dependent mechanism through the KDR receptor Arterioscler Thromb Vasc Biol 21 2001 765 770
29. T. Asahara, C. Bauters, C. Pastore, M. Kearney, S. Rossow, and S. Bunting Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery Circulation 91 1995 2793 2801
30. T. He, L.A. Smith, S. Harrington, K.A. Nath, N.M. Caplice, and Z.S. Katusic Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries Stroke 35 2004 2378 2384
31. M. Inoue, H. Itoh, M. Ueda, T. Naruko, A. Kojima, and R. Komatsu Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis Circulation 98 1998 108 116
32. F.L. Celletti, J.M. Waugh, P.G. Amabile, A. Brendolan, P.R. Hilfiker, and M.D. Dake Vascular endothelial growth factor enhances atherosclerotic plaque progression Nat Med 7 2001 425 429
33. S.C. Lee, S.J. Park, H.K. Ki, H.C. Gwon, and C.S. Chung Byun HSl. Prevalence and risk factors of silent brain infarction in apparently normal adults Hypertension 36 2000 73 77